25 of the Best Oncologists Near Me

Caitlin Borne is a Hematologist Oncology provider practicing medicine in New Orleans, Louisiana. Her clinical expertise encompasses Diffuse Large B-Cell Lymphoma (DLBCL) and Large-Cell Immunoblastic Lymphoma. Dr. Borne is board certified in American Board Of Internal Medicine - Hematology/Oncology and American Board Of Internal Medicine - Internal Medicine. Dr. Borne is currently accepting new patients.

Joshua Thomas is an Oncologist and a Hematologist practicing medicine in Frisco, Texas. His clinical expertise encompasses Triple-Negative Breast Cancer. Dr. Thomas is currently accepting new patients.

Kelley Mowatt-Pesce is a Hematologist Oncology provider practicing medicine in Hackensack, New Jersey. Her clinical expertise encompasses Sickle Cell Disease. Dr. Mowatt-Pesce is board certified in Hematology and American Board Of Internal Medicine . Dr. Mowatt-Pesce is currently accepting new patients.

David Beard is an Oncologist and a Hematologist Oncology provider practicing medicine in Woodland Hills, California. His clinical expertise encompasses Paroxysmal Nocturnal Hemoglobinuria (PNH) and Breast Cancer. Dr. Beard is board certified in Internal Medicine (Sub: Medical Oncology) and Internal Medicine. Dr. Beard is currently accepting new patients.

Megumi Tomita is an Oncologist practicing medicine in Modesto, California. Her clinical expertise encompasses Lung Cancer. Dr. Tomita is board certified in Internal Medicine (Sub: Medical Oncology) and Internal Medicine. Dr. Tomita is currently accepting new patients.

Sarah Whittier is an Oncologist and an Obstetrics and Gynecologist practicing medicine in Denver, Colorado. Her clinical expertise encompasses Li-Fraumeni Syndrome, BRCA Positive Breast Cancer, HER2 Negative Breast Cancer, and Malignant Mixed Mullerian Tumor. Dr. Whittier is board certified in American Board Of Obstetrics And Gynecology. Dr. Whittier is currently accepting new patients.

Ralph Millett, MD, is a hematologist and medical oncologist at Ochsner MD Anderson Cancer Center who treats patients in Baton Rouge and New Orleans. His research and clinical focus is thoracic medical oncology. His clinical expertise encompasses Pleuropulmonary Blastoma and Lung Cancer. Dr. Millett-Iv is board certified in American Board Of Internal Medicine - Hematology/Oncology and American Board Of Internal Medicine - Internal Medicine. Dr. Millett-Iv is currently accepting new patients.

Emily Lin is an Oncologist and a Hematologist Oncology provider practicing medicine in Portland, Oregon. Her clinical expertise encompasses Cholangiocarcinoma (Bile Duct Cancer), Prostate Cancer, and Familial Prostate Cancer. Dr. Lin is currently accepting new patients.

Thomas Drakes is an Oncologist practicing medicine in Valley Springs, California. His clinical expertise encompasses Hairy Cell Leukemia (HCL). Dr. Drakes is board certified in Internal Medicine (Sub: Medical Oncology) and Internal Medicine. Dr. Drakes is currently accepting new patients.

Valentina Ruvalcaba is an Oncologist practicing medicine in Chula Vista, California. Her clinical expertise encompasses Relapsed Refractory Multiple Myeloma (RRMM). Dr. Ruvalcaba is currently accepting new patients.

Meghan Liel is a Hematologist Oncology specialist and a Hematologist practicing medicine in Lafayette, Colorado. Her clinical expertise encompasses Hemophilia A. Dr. Liel is board certified in American Board Of Internal Medicine. Dr. Liel is currently accepting new patients.

Traveling, movies, dance. Her clinical expertise encompasses Breast Cancer. Dr. Sagaram is board certified in American Board Of Internal Medicine. Dr. Sagaram is currently accepting new patients.

Jennifer Hong is an Oncologist and a Hematologist practicing medicine in Philadelphia, Pennsylvania. Her clinical expertise encompasses Breast Cancer and Cervical Cancer. Dr. Hong is board certified in Hematology/Oncology and Internal Medicine. Dr. Hong is currently accepting new patients.

Bilal Anouti is a Hematologist and an Oncologist practicing medicine in Chicago, Illinois. He has been practicing medicine for over 10 years. His clinical expertise encompasses Lung Cancer. Dr. Anouti is board certified in American Board Of Internal Medicine - Hematology (Certified). Dr. Anouti is currently accepting new patients.

Alexander Barbaro, MD, specializes in medical oncology, hematology and internal medicine, and is an assistant professor at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell.Drawing on a lifelong love of science, Dr. Barbaro first became attracted to medicine because it combined research with making a difference in people's lives. After earning his medical degree at Temple University School of Medicine, he did a residency at Montefiore Medical Center and a fellowship at NYU Langone Health. He chose oncology as a specialty because, during training, he saw and appreciated the patient-doctor relationships forged in that field.In some specialties, you may see a patient once for 15 minutes. But with oncology, you're on a journey with a patient, you're working together, he says. You have deep, meaningful relationships and that's what attracted me, along with the innovations in cancer care, which are very exciting.Dr. Barbaro joined Northwell in 2023, in part because it allowed him to expand his ability to teach. He'd been a physics tutor in college, and then received a commendation during residency for organizing lectures for medical students. That passion for education extends to patient care because it provides a level of empowerment and advocacy that's essential for oncology patients and their families, he believes.Doctors should be teachers as well as care providers, says Dr. Barbaro. I take the approach where I'm not just spitting jargon at patients, I'm helping them understand what it means to have this diagnosis and what treatment entails. It's incredibly important to me to educate patients in a way that gives them more confidence and a sense of control over their care.He's establishing a working group at Northwell focusing on patient education, especially when it comes to side effects of new cancer therapies. His goal is to stratify risks and anticipate side effects in a way that leads to minimizing them, in order to keep boosting beneficial outcomes.In terms of what patients have taught him, Dr. Barbaro says he's learned about resiliency, particularly in the midst of a difficult diagnosis. He's often inspired by the strength of his patients, as well as that of their families and friends. Almost every day, I'm impressed by the human spirit, he says. His clinical expertise encompasses Thyroid Cancer and Salivary Gland Tumors. Dr. Barbaro is board certified in American Board Of Internal Medicine/Medical Oncology, American Board Of Internal Medicine, and American Board Of Internal Medicine/Hematology. Dr. Barbaro is currently accepting new patients.

Steven Borson is an Oncologist and a Hematologist Oncology provider practicing medicine in Sewell, New Jersey. His clinical expertise encompasses Multiple Myeloma. Dr. Borson is board certified in Hematology/Oncology. Dr. Borson is currently accepting new patients.

Moisey Khanimov, MD, is a highly skilled oncologist and hematologist specializing in the treatment of gastrointestinal malignancies both luminal and hepatobiliary. As an assistant professor at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Dr. Khanimov is dedicated to providing cutting-edge and compassionate care to his patients.Dr. Khanimov completed his medical degree at SUNY Upstate Medical University College of Medicine and went on to complete his residency and chief residency in Internal Medicine at North Shore-Long Island Jewish Health System. He furthered his expertise with a fellowship specializing in Hematology/Oncology at Montefiore Medical Center - Moses Division.With a particular interest in luminal and hepatobiliary cancers, Dr. Khanimov has spent the second half of his fellowship exclusively dedicated to treating patients with gastrointestinal malignancies. He is committed to staying at the forefront of his field and utilizes the latest advancements and evidence-based practices in cancer treatment.Dr. Khanimov sees patients at the Northwell Health Cancer Institute in Rego Park, where he provides personalized and comprehensive care to individuals facing a cancer diagnosis. He is board-certified in Internal Medicine, Hematology, and Oncology by the American Board of Internal Medicine.In addition to his clinical practice, Dr. Khanimov holds an academic title as Assistant Professor at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. He is passionate about education and mentorship, actively participating in the training of future physicians.With his extensive knowledge and compassionate approach, Dr. Moisey Khanimov is dedicated to delivering outstanding care and helping patients on their journey to recovery. His clinical expertise encompasses Colorectal Cancer, Esophageal Cancer, Stomach Cancer, and Intestinal Cancer. Dr. Khanimov is board certified in American Board Of Internal Medicine/Medical Oncology, American Board Of Internal Medicine, and American Board Of Internal Medicine/Hematology. Dr. Khanimov is currently accepting new patients.

Alice Lee, MD, is Director, Early Phase Clinical Trials program and Director, Pediatric Sarcoma program at the Children’s Hospital at Montefiore Einstein and Assistant Professor, Pediatrics at our Albert Einstein College of Medicine. Dr. Lee’s clinical focus is on the treatment of children and young adults with sarcomas. She also has special interest in novel treatments for children with relapsed or refractory cancers. Her clinical expertise encompasses Immune Thrombocytopenic Purpura (ITP). Dr. Lee is currently accepting new patients.

Paige Ganem is a Hematologist Oncology provider practicing medicine in Greenville, South Carolina. Dr. Ganem is board certified in American Board Of Internal Medicine. Dr. Ganem is currently accepting new patients.

As a member of the Duke Cancer Network, my goal is to provide top notch care for all my patients close to home. The collaboration with Duke provides our patients access to cutting edge research and clinical trials. I treat all types of cancers and many blood related disorders. I believe in patient centered care where my role is to explain diagnosis and treatment options in a way they can understand and are able to make decisions. Other than medicine, I love spending time with my family, cooking, and gardening. Dr. Vishnuvardhan is board certified in American Board Of Internal Med, Medical Oncology , American Board Of Internal Med, Hematology, and American Board Of Internal Med, Internal Medicine . Dr. Vishnuvardhan is currently accepting new patients.

Gideon Dosunmu is an Oncologist practicing medicine in Atlanta, Georgia. Dr. Dosunmu is board certified in American Board Of Internal Medicine. Dr. Dosunmu is currently accepting new patients.

I am a medical oncologist who specializes in the care of patients with breast cancer. I chose this field because it allows me to guide, support, and comfort my patients through some of the most meaningful and challenging moments of their lives - from the uncertainty of a new cancer diagnosis to the excitement of a remission to the complexity of end-of-life decisions. I am originally from North Carolina, and after completing my medical training at Johns Hopkins, I am honored to return home to serve my community as a breast medical oncologist. Outside of work, I enjoy spending time with my family, hiking with my rescue dog, and reading/writing creative nonfiction. Dr. Verma is currently accepting new patients.

Dr. Anagnostou is an Associate Professor of Oncology, co-director of the Upper Aerodigestive Malignancies Program, director of the Thoracic Oncology Biorepository, leader of Precision Oncology Analytics and co-leader of the Molecular Tumor Board and the Thoracic Oncology Precision Medicine Center of Excellence in the Sidney Kimmel Cancer Center at Johns Hopkins. She has established the Molecular Oncology laboratory that seeks to understand the genomic wiring of response and resistance to immunotherapy through integrative genomic, transcriptomic, single-cell and liquid biopsy analyses of tumor and immune evolution. Dr. Anagnostou graduated from Medical School of the National and Kapodistrian University of Athens, Greece and received a PhD from the same institution. After completing her internal medicine residency at Yale-New Haven Hospital, she subsequently trained in Medical Oncology at Johns Hopkins. Dr. Anagnostou is a translational cancer investigator, focusing on large-scale genomic and liquid biopsy analyses in human cancers. Her group has discovered novel genomic mechanisms of response and resistance to immunotherapy and her research is particularly focused on understanding the molecular mechanisms of response and resistance to these therapies, capturing these by minimally invasive methods and translating this knowledge into novel technologies and innovative therapeutic approaches for cancer patients. She is the international study chair of the first ctDNA-based molecular response adaptive immuno-chemotherapy clinical trial for metastatic non-small cell lung cancer (NCT04093167). Dr. Anagnostou's long term goal is to transform medical oncology to personalized molecular oncology, where treatment decisions are tailored to cancer genomics and molecular real-time response assessments informed by liquid biopsies. Her clinical expertise encompasses Lung Cancer. Dr. Anagnostou is currently accepting new patients.

Geraldine O'Sullivan Coyne, MD, PhD, MRCPI, is the system head of Northwell and director of clinical research at New York State's first START Center for Cancer Research site, located at the R.J. Zuckerberg Cancer Center at Long Island Jewish Medical Center. START is a global network of sites focused on bringing early-phase oncology trials to community-based centers.She joins Northwell Health after two years as a clinical investigator at START Dublin in Ireland. Prior to that, Dr. O'Sullivan spent 10 years at the National Cancer Institute in Bethesda, Maryland, where she completed fellowships in hematology/oncology and advanced developmental therapeutics, and held leadership roles including staff clinician in the Developmental Therapeutics Clinic (DTC) and Early Clinical Trials Development Program.Dr. O'Sullivan received her medical training at the Royal College of Physicians of Ireland and earned a PhD in molecular medicine from University College Cork School of Medicine's Cork Cancer Research Center. Her years of education and experience have generated more than 100 published research works, numerous clinical awards and international recognition and respect.Her aim now is to partner the expertise and resources of Northwell with START to bring cutting-edge early-stage oncology trials to Long Island. Traditionally, clinical trials have been predominantly run at large academic centers. Unless you live nearby, you have to leave your local system and potentially travel a great distance to participate. Now, FDA-regulated trials will be available where our patients live for a wide breadth of solid tumors and hematological malignancies, including both common and rare cancers.An additional focus for Dr. O'Sullivan is improving patient safety. In the modern era, the molecules we're working with are very strong and targeted, but just because they are at earlier stages of development doesn't mean they are unsafe or ineffective. I want patients to know how important their safety is to me, and that most of the drugs will go on to later stage trials. Interacting with patients is hands down my favorite part of this job. Their safety is my number one priority. Dr. Coyne is currently accepting new patients.

Sarah Podwika, MD, is an OB-GYN who specializes in caring for patients with gynecologic cancers, including uterine, ovarian, cervical, vulvar and vaginal. She performs surgeries and collaborates with a multidisciplinary team of oncologists and radiation oncologists to provide comprehensive treatment.|A caring and compassionate provider, Dr. Podwika finds joy in getting to know her patients and helping them through their cancer journey. “It is an honor to be part of their care team,” she shares. “While a cancer diagnosis is never easy, I'm optimistic about the advancements in treatments and options available to our patients.”|Dr. Podwika earned her Doctor of Medicine and Master of Public Health degrees from the University of Virginia School of Medicine. Throughout her academic career, she received numerous grants and scholarships, such as the Peyton T. Taylor Endowed Research Scholarship for innovative research strategies. She was also recognized for her excellence in teaching, teamwork and patient care with multiple awards.|Committed to advancing the field of obstetrics and gynecology, Dr. Podwika's research interests include cervical cancer testing and healthcare reimbursement for gynecologic procedures. She has contributed to several peer-reviewed publications and has volunteered and conducted research in countries like Rwanda, Tanzania, and Guatemala.|Before pursuing medicine, Dr. Podwika worked as a certified public accountant. When she's not attending to her hospital duties, she enjoys spending quality time with her husband and children. She is excited to be back in central Pennsylvania, where she was raised. Dr. Podwika is currently accepting new patients.